GILEAD SCIENCES, INC. STOCK OPTION AGREEMENTStock Option Agreement • February 27th, 2008 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • California
GILEAD SCIENCES, INC. STOCK OPTION AGREEMENTStock Option Agreement • February 27th, 2008 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • California
COMMERCIALIZATION AGREEMENT BETWEEN GILEAD SCIENCES LIMITED AND BRISTOL-MYERS SQUIBB COMPANY DATED AS OF DECEMBER 10, 2007Commercialization Agreement • February 27th, 2008 • Gilead Sciences Inc • Biological products, (no disgnostic substances)
This COMMERCIALIZATION AGREEMENT (this “Agreement”) dated and effective as of December 10, 2007 (the “Effective Date”) is hereby made by and between Gilead Sciences Limited, a limited company organized and existing under the laws of Ireland, having offices at Unit 13 Stillorgan Industrial Park, Blackrock, Co. Dublin, Ireland (“Gilead Sub”), and Bristol-Myers Squibb Company, a corporation organized and existing under the laws of Delaware, having offices at 345 Park Avenue, New York, New York 10154, USA (“BMS”) (each of Gilead Sub and BMS, a “Party” and, collectively, the “Parties”).
